Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts

scientific article published on January 24, 1977

Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0006-291X(77)90363-1
P698PubMed publication ID836321

P2093author name stringJ. Spranger
J. Gehler
M. Cantz
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)732-738
P577publication date1977-01-01
1977-01-24
P1433published inBiochemical and Biophysical Research CommunicationsQ864228
P1476titleMucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts
P478volume74

Reverse relations

cites work (P2860)
Q42440744A case of mucolipidosis II: Biochemical, nutritional, and immunological studies
Q41554416A case of neuraminidase deficiency associated with a partial beta-galactosidase defect. Clinical, biochemical and radiological studies
Q41491200A method for enrichment of hybrid somatic cells: complementation studies in certain lysosomal enzymopathies
Q70283213A rapid and sensitive assay for neuraminidase using peanut lectin hemagglutination: Application to Vibrio cholera and Trypanosoma cruzi
Q66953185A rapid and sensitive assay for neuraminidase: Application to cultured flbroblasts
Q71144793A severe infantile sialidosis: clinical, biochemical, and microscopic features
Q39291893Acid acylhydrolase deficiency in I-cell disease and pseudo-hurler polydystrophy
Q39722186Adult type GMl-gangliosidosis: A complementation study on somatic cell hybrids
Q66991225Adult type neuronal storage disease with neuraminidase deficiency
Q72848920Affinity chromatography of lysosomal enzymes in plasma, urine and fibroblasts of patients with mucolipidosis (ML) II and III
Q35966074Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography-mass spectrometry
Q44007899Beta-galactosidase deficient-type mucolipidosis: A complementation study of neuraminidase in somatic cell hybrids
Q67251308Biochemical basis of six different types of sialidosis
Q70764611Caprine beta-mannosidosis. Inherited deficiency of beta-D-mannosidase
Q36812239Catabolic disorders of complex carbohydrates
Q43775457Cellular localization of neuraminidases in cultured human fibroblasts
Q42875100Characterization of human placental neuraminidases. Stability, substrate specificity and molecular weight
Q41607943Characterization of neuraminidase activity of cultured human fibroblasts
Q39241410Cherry-red spot myoclonus syndrome and alpha-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult
Q28273887Combined deficiency of beta-galactosidase and neuraminidase: three affected siblings in a French family
Q71132519Deficiency of methylumbelliferyl-alpha-Neuraminic acid neuraminidase in the sialidoses and mucolipidosis II and III
Q71185005Deficiency of neuraminidase in the sialidoses and the mucolipidoses
Q28302956Disorders of glycoprotein degradation
Q41940652Effects of neuraminidase on the phenotype of sindbis virus grown in fibroblasts obtained from patients with I-cell disease
Q90222396Exploration of the Sialic Acid World
Q39618263GM1-gangliosidosis: Accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types
Q24309596Galactosialidosis: simultaneous deficiency of esterase, carboxy-terminal deamidase and acid carboxypeptidase activities
Q52109078Genetic diagnostic studies for mental retardation.
Q52104266Genetic heterogeneity in human neuraminidase deficiency.
Q67262700I-cell disease Desialylation of β-hexosaminidase and its effect on uptake by fibroblasts
Q41040230I-cell disease. A hypothesis for the structure of the carbohydrate recognition site on beta-D-N-acetylhexosaminidase
Q41352808I-cell disease: Isoelectric focusing, concanavalin asepharose 4B binding and kinetic properties of human lier acid β-d-galactosidases
Q34133659Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient.
Q34480848Inborn errors of lysosomal catabolism—principles of heterozygote detection
Q71065767Influence of sialic acid on cell surface properties in I-cell disease fibroblasts
Q34498745Inherited lipid storage diseases of the central nervous system
Q38357734Isolation and Characterization of Phosphorylated Oligosaccharides from alpha-N-Acetylglucosaminidase that Are Recognized by Cell-Surface Receptors
Q34364491Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology
Q39605242Macular cherry-red spots and myoclonus with dementia: Coexistent neuraminidase and β-galactosidase deficiencies
Q36305733Molecular defect in combined beta-galactosidase and neuraminidase deficiency in man.
Q43801611Mucolipidosis I — A sialidosis
Q70659814Mucolipidosis I. Roentgenographic follow-up
Q70757490Mucolipidosis I: Studies of sialidase activity and a prenatal diagnosis
Q66979017Mucolipidosis type IV: Ganglioside sialidase deficiency
Q30313613Multigene panel next generation sequencing in a patient with cherry red macular spot: Identification of two novel mutations in NEU1 gene causing sialidosis type I associated with mild to unspecific biochemical and enzymatic findings
Q33940580Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex
Q42501824Nephrosialidosis: ultrastructural and lectin histochemical study
Q39682355Neuraminidase activity in liver and brain from patients with i-cell disease
Q45130639Neuraminidase activity in the mucolipidoses (types I, II and III) and the cherry-red spot myoclonus syndrome
Q67060032Neuraminidase deficiency in the cherry red spot-myoclonus syndrome
Q66980431Neuraminidase deficiency in the mouse
Q44925622Neuraminidase deficiency in the original patient with the Goldberg Syndrome
Q72834626Neuraminidase deficiency presenting as non-immune hydrops fetalis
Q66978399Neuraminidase in Cultured Fibroblasts and Leucocytes of Homozygotes and Heterozygotes for the Mucolipidosis II Gene (I-Cell Disease)
Q39698667Neuraminidase in mucolipidoses: Normal activity in frozen autopsy tissues from three patients with I-cell disease and adult β-galactosidase deficiency
Q44567585Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria
Q44824438Oligosaccharide and Ganglioside Neuraminidase Activities of Mucolipidosis I (Sialidosis) and Mucolipidosis II (I-Cell Disease) Fibroblasts
Q36649026Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis
Q68372756Photoaffinity labeling of the lysosomal neuraminidase from bovine testis
Q40245324Prenatal diagnosis of inherited metabolic diseases; principles, pitfalls, and prospects.
Q39677198Progressive myoclonus epilepsy. A variant with probable X-linked inheritance
Q70337852Purification and characterization of sialic acid containing materials accumulated in cultured skin fibroblasts from a patient with type II sialidosis
Q35595384Sialidosis and galactosialidosis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders
Q88469040Sialidosis: A Review of Morphology and Molecular Biology of a Rare Pediatric Disorder
Q33898281Sialidosis: a review of human neuraminidase deficiency
Q42271895Structure of the lysosomal neuraminidase-beta-galactosidase-carboxypeptidase multienzymic complex
Q67654120Structures of sialyl-oligosaccharides excreted in the urine of a patient with mucolipidosis I
Q33264100The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin
Q40156522The cherry-red spot-myoclonus syndrome
Q70467704The simple detection of neuraminic acid-containing urinary oligosaccharides in patients with glycoprotein storage diseases
Q54293746The synthesis of 4-methylumbelliferyl α-ketoside of N-acetylneuraminic acid and its use in a fluorometric assay for neuraminidase
Q39296453The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis
Q28367281Turnover of beta-galactosidase in fibroblasts from patients with genetically different types of beta-galactosidase deficiency
Q40258751Urinary oligosaccharide excretion in disorders of glycolipid, glycoprotein and glycogen metabolism. A review of screening for differential diagnosis
Q40332474Urinary oligosaccharides in lysosomal and other metabolic disorders.

Search more.